These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 14671028

  • 61. [Diabetes mellitus complicated with hyperlipidemia].
    Ota Y, Gotoda T.
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():424-9. PubMed ID: 12430264
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. [Nicotinic acid and the derivative].
    Ogaki S, Matsushima T.
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():637-41. PubMed ID: 11347146
    [No Abstract] [Full Text] [Related]

  • 65. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
    Rabar S, Harker M, O'Flynn N, Wierzbicki AS, Guideline Development Group.
    BMJ; 2014 Jul 17; 349():g4356. PubMed ID: 25035388
    [No Abstract] [Full Text] [Related]

  • 66. Clinical trials: Evidence and unanswered questions--hyperlipidaemia.
    Deanfield JE.
    Cerebrovasc Dis; 2003 Jul 17; 16 Suppl 3():25-32. PubMed ID: 12740553
    [Abstract] [Full Text] [Related]

  • 67. Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantation.
    Garcia I, Errasti P, Lavilla FJ, Ballester B, Manrique J, Rossich E, Purroy A.
    Transplant Proc; 2002 Feb 17; 34(1):401-2. PubMed ID: 11959344
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Simplifying the approach to the management of dyslipidemia.
    Gaziano JM, Gaziano TA.
    JAMA; 2009 Nov 18; 302(19):2148-9. PubMed ID: 19920241
    [No Abstract] [Full Text] [Related]

  • 72. Statin induced myotoxicity.
    Sathasivam S.
    Eur J Intern Med; 2012 Jun 18; 23(4):317-24. PubMed ID: 22560377
    [Abstract] [Full Text] [Related]

  • 73. Therapy and clinical trials.
    Seed M.
    Curr Opin Lipidol; 1996 Oct 18; 7(5):U168-72. PubMed ID: 8937532
    [No Abstract] [Full Text] [Related]

  • 74. Commentary: Controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease.
    Cappuccio FP.
    BMJ; 2008 May 31; 336(7655):1248-9. PubMed ID: 18511801
    [No Abstract] [Full Text] [Related]

  • 75. Drug treatment of lipid disorders.
    Knopp RH.
    N Engl J Med; 1999 Aug 12; 341(7):498-511. PubMed ID: 10441607
    [No Abstract] [Full Text] [Related]

  • 76. Why do statins reduce cardiovascular disease more than other lipid modulating therapies?
    Schooling CM, Au Yeung SL, Leung GM.
    Eur J Clin Invest; 2014 Nov 12; 44(11):1135-40. PubMed ID: 25252212
    [No Abstract] [Full Text] [Related]

  • 77. Managing hyperlipidemia: current and future roles of HMG-CoA reductase inhibitors.
    Lopez LM.
    Am J Health Syst Pharm; 2002 Jun 15; 59(12):1173-9; quiz 1180-2. PubMed ID: 12073858
    [Abstract] [Full Text] [Related]

  • 78. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH, Heckbert SR, de Boer A, Leufkens HG, Sullivan SD, Fishman PA, Veenstra DL, Psaty BM.
    Ann Pharmacother; 2002 May 15; 36(5):751-7. PubMed ID: 11978147
    [Abstract] [Full Text] [Related]

  • 79. Additional insights on how best to utilize statins.
    Feeman WE.
    J Fam Pract; 2014 Mar 15; 63(3):128. PubMed ID: 24701605
    [No Abstract] [Full Text] [Related]

  • 80. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
    Kawada-Watanabe E, Ogawa H, Koyanagi R, Arashi H, Yamaguchi J, Matsui K, Hagiwara N.
    J Cardiol; 2017 Mar 15; 69(3):536-541. PubMed ID: 27349705
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.